Chemiesynth (Vapi) (BSE 539230)₹160.700.00%Specialty Chemicals
In the Mar 2026 quarter (standalone), Chemiesynth (Vapi) reported sales of ₹5.49 Cr, down 17.7% from Mar 2025, and net profit of ₹0.61 Cr, up 205.0% year on year. For the year to Mar 2026, sales were ₹21.42 Cr and net profit −₹1 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.38 | 4.36 | 3.21 | 4.44 | 2.84 | 5.46 | 3.87 | 6.67 | 3.96 | 6.86 | 5.08 | 5.49 |
| Expenses | 4.49 | 3.01 | 3.32 | 4.11 | 2.67 | 4.52 | 3.66 | 5.88 | 3.80 | 6.69 | 5.16 | 4.46 |
| Operating Profit | −0.08 | 1.36 | −0.08 | 0.34 | 0.18 | 0.95 | 0.22 | 0.80 | 0.17 | 0.18 | −0.05 | 1.04 |
| OPM % | −2.0% | 31.3% | −2.8% | 7.9% | 6.7% | 17.5% | 5.9% | 12.1% | 4.5% | 2.8% | −1.2% | 19.1% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.13 | 0.22 | 0.12 | 0.25 | 0.10 | 0.16 | 0.33 | 0.19 | 0.26 | 0.26 | 0.25 | 0.23 |
| Depreciation | 0.29 | 0.31 | 0.31 | 0.35 | 0.33 | 0.37 | 0.35 | 0.32 | 0.38 | 0.35 | 0.37 | 0.29 |
| Profit before tax | −0.52 | 0.85 | −0.53 | −0.27 | −0.25 | 0.42 | −0.48 | 0.30 | −0.47 | −0.45 | −0.71 | 0.55 |
| Tax % | 0.0% | 0.0% | 0.0% | −23.0% | 0.0% | 0.0% | 0.0% | 34.5% | 0.0% | 0.0% | 0.0% | −11.1% |
| Net Profit | −0.50 | 0.86 | −0.53 | −0.21 | −0.23 | 0.43 | −0.48 | 0.20 | −0.45 | −0.43 | −0.69 | 0.61 |
| EPS (Rs) | −1.65 | 2.76 | −1.68 | −0.64 | −0.77 | 1.36 | −1.52 | 0.61 | −1.49 | −1.42 | −2.27 | 1.94 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.11 | 3.08 | 13.30 | 11.18 | 14.53 | 19.87 | 30.14 | 20.89 | 16.39 | 18.86 | 21.42 | 21.39 |
| Expenses | 5.27 | 3.18 | 12.68 | 9.27 | 12.29 | 14.33 | 25.74 | 18.40 | 14.89 | 16.69 | 20.12 | 20.11 |
| Operating Profit | −0.13 | −0.07 | 0.64 | 1.93 | 2.28 | 5.56 | 4.45 | 2.56 | 1.54 | 2.20 | 1.34 | 1.34 |
| OPM % | −2.7% | −2.6% | 4.9% | 17.3% | 15.7% | 28.1% | 14.8% | 12.3% | 9.4% | 11.7% | 6.3% | 6.3% |
| Other Income | 0.02 | 0.26 | 0.45 | 0.05 | 0.11 | 0.01 | 0.93 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.24 | 0.20 | 0.20 | 0.08 | 0.29 | 0.47 | 0.49 | 0.58 | 0.70 | 0.82 | 1.00 | 1.00 |
| Depreciation | 0.19 | 0.17 | 0.51 | 0.45 | 0.54 | 0.77 | 1.04 | 1.16 | 1.29 | 1.39 | 1.41 | 1.39 |
| Profit before tax | −0.55 | −0.19 | 0.41 | 1.46 | 1.59 | 4.36 | 3.87 | 0.82 | −0.46 | −0.02 | −1.06 | −1.08 |
| Tax % | 0.0% | 0.0% | 0.0% | 19.4% | 17.2% | 17.8% | 29.9% | 32.2% | −13.3% | 1,000.1% | −5.7% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | −0.55 | −0.17 | 0.38 | 1.16 | 1.32 | 3.57 | 2.71 | 0.57 | −0.40 | −0.12 | −1.00 | −0.96 |
| EPS (Rs) | −1.75 | −0.58 | 1.26 | 3.80 | 4.26 | 11.56 | 8.83 | 1.81 | −1.26 | −0.35 | −3.21 | −3.24 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.06 | 3.06 | 3.06 | 3.06 | 3.06 | 3.06 | 3.06 | 3.06 | 3.06 | 3.06 | 3.06 | 3.06 |
| Reserves | −0.29 | −0.82 | −1.06 | −0.67 | 0.52 | 1.83 | 5.38 | 8.08 | 8.65 | 8.25 | 7.89 | 6.96 |
| Borrowings | 6.69 | 8.15 | 8.01 | 8.00 | 7.68 | 9.72 | 10.84 | 11.57 | 13.60 | 15.50 | 14.98 | 15.99 |
| Other Liabilities | 2.73 | 1.26 | 1.57 | 1.47 | 3.57 | 3.16 | 7.52 | 6.83 | 5.62 | 4.46 | 6.16 | 5.92 |
| Total Liabilities | 12.19 | 11.65 | 11.58 | 11.86 | 14.83 | 17.77 | 26.80 | 29.54 | 30.93 | 31.27 | 32.09 | 31.93 |
| Fixed Assets | 10.06 | 9.95 | 9.68 | 9.59 | 10.65 | 12.27 | 20.33 | 22.30 | 24.44 | 24.99 | 25.74 | 27.20 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 1.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 2.13 | 1.70 | 1.90 | 2.27 | 3.93 | 4.15 | 6.47 | 7.24 | 6.49 | 6.28 | 6.35 | 4.73 |
| Inventories | 0.75 | 0.64 | 0.96 | 0.35 | 1.20 | 1.78 | 1.42 | 2.16 | 2.89 | 3.27 | 1.96 | 1.89 |
| Trade receivables | 0.81 | 0.43 | 0.20 | 0.98 | 1.68 | 1.58 | 3.69 | 3.43 | 2.70 | 2.11 | 2.84 | 1.76 |
| Cash & equivalents | 0.11 | 0.09 | 0.13 | 0.14 | 0.53 | 0.32 | 0.42 | 1.02 | 0.03 | 0.05 | 0.03 | 0.03 |
| Total Assets | 12.19 | 11.65 | 11.58 | 11.86 | 14.83 | 17.77 | 26.80 | 29.54 | 30.93 | 31.27 | 32.09 | 31.93 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −0.17 | −1.49 | −0.14 | 0.55 | 2.55 | 1.27 | 6.48 | 2.91 | 0.28 | −0.04 | 2.66 | 1.90 |
| Cash from investing activity | 0.05 | −0.07 | 0.31 | −0.37 | −1.70 | −3.19 | −7.50 | −3.04 | −3.28 | −1.86 | −2.13 | −2.90 |
| Cash from financing activity | −0.14 | 1.58 | −0.17 | −0.17 | −0.46 | 1.71 | 1.14 | 0.75 | 2.05 | 1.91 | −0.53 | 1.02 |
| Net cash flow | −0.24 | −0.03 | 0.02 | 0.02 | 0.39 | −0.21 | 0.12 | 0.60 | −0.99 | 0.00 | 0.00 | 0.00 |
| Capex | 0.09 | 0.14 | 0.23 | 0.94 | 1.87 | 3.46 | 7.61 | 3.08 | 3.32 | 1.88 | 2.17 | 3.07 |
| Free cash flow | −0.12 | −1.60 | 0.19 | 0.18 | 0.84 | −1.94 | −1.03 | −0.16 | −3.03 | −1.91 | 0.51 | −1.04 |
| CFO / OP % | 38.0% | 1,071.0% | 162.1% | 86.0% | 145.0% | 66.1% | 122.0% | 89.1% | 32.0% | 8.1% | 121.0% | 139.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 27 | 31 | 25 | 27 | 55 | 40 | 68 | 42 | 47 | 47 | 55 | 30 |
| Inventory days | 46 | 137 | 581 | 17 | 232 | 218 | 166 | 82 | 201 | 387 | 169 | 131 |
| Days payable | 127 | 159 | 742 | 44 | 606 | 366 | 695 | 159 | 201 | 112 | 202 | 193 |
| Cash conversion cycle | −56 | 7 | −138 | −1 | −320 | −110 | −463 | −38 | 46 | 320 | 20 | −34 |
| Working capital days | −55 | −49 | −105 | −10 | −30 | −62 | −67 | −51 | −67 | −106 | −123 | −150 |
| ROCE % | −6.9% | −3.2% | −2.4% | 5.3% | 13.8% | 14.0% | 28.4% | 16.4% | 5.9% | 1.0% | 3.1% | −0.2% |
For the Mar 2026 quarter, Chemiesynth (Vapi) reported sales of ₹5.49 Cr, down 17.7% year on year and net profit of ₹0.61 Cr, up 205.0% year on year. The operating margin was 19.1%.
Chemiesynth (Vapi)'s sales for the year to Mar 2026 were ₹21.42 Cr; over the last twelve months they were ₹21.39 Cr.
Net profit for the year to Mar 2026 was −₹1 Cr, and −₹0.96 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−3.24.
Chemiesynth (Vapi) reported borrowings of ₹15.99 Cr at Mar 2026, against cash and equivalents of ₹0.03 Cr.
Cash from operations was ₹1.90 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹1.04 Cr.